In particular, Tregs express the inhibitory immune checkpoint molecule cytotoxic T-lymphocyte (associated) antigen 4 (CTLA-4), which plays a critical role in the regulation of T cell-mediated anti-tumor immunity. Here, CTLA4 is linked to neoplasm.